Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07422090Recruiting

Preventing Suicide With Digital Phenotyping and Pharmacogenetics-Based Interventions

Role: collaborator

NCT07206095Recruiting

Integrative Diagnosis for SCD and Other RADs

Role: collaborator

NCT06855056Recruiting

Validation of New Prognostic Biomarkers in Patients With Decompensated Cirrhosis

Role: collaborator

NCT07065825Not Yet Recruiting

Tumor Rupture During Robotic Partial Nephrectomy

Role: collaborator

NCT06996197Not ApplicableCompleted

Bioelectric Impedance in Non-invasive Ventilated Patients: The NIVAR Study.

Role: collaborator

All 5 trials loaded